Influenza surveillance in England and Wales: October 1999 to May 2000. 2000

N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
Respiratory Disease Section, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ. ngoddard@phls.org.uk

The period of increased influenza activity in England and Wales in the winter of 1999/2000 was associated with considerable morbidity and mortality and well-publicized pressure on hospital services. The influenza activity coincided with the regular annual increase in respiratory syncytial virus infections and the Christmas and New Year holiday period. Consultation rates with general practitioners for influenza-like illness did not reach 'epidemic' levels but were higher than seen in many winters and comparable with those seen in two out of the previous three winters. In common with those winters, attack rates for influenza-like illness and acute bronchitis were especially high in elderly people among whom complications of acute infection and hospital admissions increased. Excess mortality due to influenza during this period appeared to be substantial but was not as high as seen in the last epidemic (1989/90).

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females

Related Publications

N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1999, Communicable disease and public health,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1994, Communicable disease report. CDR review,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1997, Communicable disease report. CDR review,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1998, Communicable disease and public health,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1995, Communicable disease report. CDR review,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
November 1996, Communicable disease report. CDR review,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
December 1993, Communicable disease report. CDR review,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
June 2000, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
November 2000, Communicable disease report. CDR supplement,
N L Goddard, and C A Joseph, and M Zambon, and M Nunn, and D Fleming, and J M Watson
November 2017, The Veterinary record,
Copied contents to your clipboard!